期刊文献+

中国土家族人群血管紧张素原和血管紧张素转化酶基因多态性与冠心病的关系 被引量:2

Association between the gene polymorphism of angiotensinogen and angiotensin converting enzyme and coronary artery disease
下载PDF
导出
摘要 目的研究血管紧张素原(AGT)基因M235T分子变异和血管紧张素转化酶(ACE)基因I/D多态性与冠状动脉粥样硬化的关系。方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测冠心病(CHD)组137例和健康对照组125例AGT基因多态性,采用聚合酶链反应技术检测CHD组和健康对照组ACE基因I/D多态性。结果 CHD组AGT-TT基因型频率为75.91%,显著高于健康对照组43.20%(P<0.01);ACE-DD基因型频率为35.77%,显著高于健康对照组15.20%(P<0.01)。结论在中国土家族人群中,AGT基因TT基因型和ACE基因DD基因型是CHD发病既相互独立又具有协同作用的危险因子。 Objective To investigate the relation between the polymorphisms of angiotensinogen (ACT) gene- type M235T and angiotensin-converting enzyme (ACE) genetype I/D and coronary atherosclerosis. Methods The study population was consisted of 151 patients with coronary heart disease (CHD), and the healthy control group was consisted of 127 patients without CHD. Patients with CHD were compared with those persons in the healthy control group. ACT gene polymorphisms was tested with polymerase chain reaction and restriction fragment length polymor- phism (PCR-RFLP) technology and ACE gene polymorphism was tested with PCR. Results The ratios of AGT_'IT and ACE-DD genetype in CHD group were 75.91% and 43.20%, respectively, which were significantly higher than that of control group (35.77% and 15.20% ). There was significant difference of the ACT_'TT genetype between the CHD group and the control group (P〈0.01) ,so was ACE-DD genetype between the two group (P〈0.01). Conclusion In the population of Chinese miao nationality, the gene polymorphisms of genetype AGT-TT and genetype ACE-DD are two risk factors of CHD morbidity and they are both independent of each other,but also mutually coordinated.
出处 《检验医学与临床》 CAS 2013年第7期816-818,共3页 Laboratory Medicine and Clinic
关键词 冠状动脉粥样硬化 血管紧张素原 血管紧张素转化酶 聚合酶链反应 基因多态性 coronary atherosclerosis angiotensinogen angiotensin converting enzyme polymerase chain reaction gene polymorphism
  • 相关文献

参考文献10

  • 1Taverne K,de Groot M, de Boer A, et al. Genetic poly-morphisms related to the renin-angiotensin-aldosteronesystem and response to antihypertensive drugs[J]. ExpertOpin Drug Metab Toxicol,2010,6(4) :439-460.
  • 2Sobstyl J , Dzida G, Puoniak A, et al. Angiotensin-conver-ting enzyme gene insertion/deletion polymorphism in Pol-ish patients with myocardial infarction [ J]. Ann UnivMariae Curie Sklodowska Med,2002,57(2) :21-28.
  • 3Brand E,Chatelain N,Paillard F,et al. Detection of puta-tive functional angiotensinogen( AGT) gene variants con-trolling plasma AGT levels by combined segregation-link-age analysis [J]. Eur J Hum Genet,2002 ,10(11):715-723.
  • 4Niu T, Chen X,Xu X. Angiotensin converting enzymegene insertion/deletion polymorphism and cardiovasculardisease; therapeutic implications[J]. Drugs,2002,62 (7):977-993.
  • 5Winkelmann BR,Russ AP, Nauck M, et al. Angiotensino-gen M235T polymorphism is associated with plasma an-giotensinogen and cardiovascular disease[J]. Am Heart J,1999,137(4 Pt 1) :698-705.
  • 6Rush JW, Aultman ('D. Vascular biology of angiotensinand the impact of physical activity[J]. Appi Physiol NutrMetab,2008,33(1) :162-172.
  • 7牛云茜,罗礼云,彭健,梅啸,彭澍,龚五星.肾素-血管紧张素系统基因多态性与冠心病合并慢性心力衰竭的关系[J].中山大学学报(医学科学版),2008,29(2):168-172. 被引量:10
  • 8Gross CM, Perrot A. Geier C,et al. Recurrent in-stentrestenosis is not associated with the angiotensin-conver-ting enzyme D/1, angiotensinogen Thrl74Met andMet235Thr, and the angiotensin-II receptor 1 Al 166Cpolymorphism[J]. J Invasive Cardiol, 2007 ,19 (6): 261-264.
  • 9Kamitani A, Rakugi H,Higaki J,et al. Enhanced predicta-bility of myocardial infarction in Japanese by combinedgenotype analysis [ J]. Hypertension, 1995, 25 ( 5 ) : 950-953.
  • 10祝有国,王福军,符自清,向亚东.中国苗族人群血管紧张素原和血管紧张素转化酶基因多态性与冠心病的关系[J].中国动脉硬化杂志,2010,18(5):405-408. 被引量:5

二级参考文献15

共引文献13

同被引文献31

  • 1Nakase T, Mizuno T, Harada S,et al. Angiotensinogen genepolymorphismas a risk factor for lischemic stroke [J]. J ClinNeurosci, 2007,14(10): 943-947.
  • 2Munshi A, Sharma V, Kaul S,et al. Association of the-344C/T aldosterone synthase (CYP11B2) gene variant withhypertensionand stroke [J]. J Neurol Sci, 2010,296 (1-2):34-38.
  • 3Saidi S, Mahjoub T, Almawi WY. Aldosterone synthase gene(CYP11B2) promoter polymorphism as a risk factor forischaemicstroke in Tunisian Arabs [J]. J Renin AngiotensinAldosterone Syst, 2010,11 (3): 180-186.
  • 4Jia EZ, Xu ZX, Guo CY, et al. Renin-angiotensin-aldosteronesystem gene polymorphisms and coronary artery disease:detection of gene-gene and gene-environment interactions [J].Cell Physiol Biochem, 2012,29 ?3-4): 443-452.
  • 5Turgut SAkin F, Akcilar R. Angiotensin converting enzymeI/D, angiotensinogen M235T and AT1-R A/Cl 166 genepolymorphisms in patients with acromegly[J]. Mol Biol Rep,2011,38(1): 569-576.
  • 6Chang SN,Lin JW, Juang JM, et al. Association betweengenetic polymorphisms in the renin-angiotensin system andsystolic heart failure revised by a propensity score-basedanalysis [J]. Cardiology, 2010, 116(4): 279-285.
  • 7Saidi S, Mallat SG, Almawi WY, et al. Association betweenrenin-angiotensin-aldosterone system genotypes and haplotypesand risk of ischemi stroke of atherosclerotic etiology [J]. ActaNeurologica Scandinavica, 2009, 119(6): 356-363.
  • 8张勇,金水晶,周代锋,张云霞,陈少华,李林江,王镇,吴恳,习隽丽,陈照清.血管紧张素原基因两个多态位点与海南地区汉族脑梗死的关系[J].中国老年学杂志,2010,30(9):1189-1190. 被引量:4
  • 9祝有国,王福军,符自清,向亚东.中国苗族人群血管紧张素原和血管紧张素转化酶基因多态性与冠心病的关系[J].中国动脉硬化杂志,2010,18(5):405-408. 被引量:5
  • 10刘立伟,陈国良,刘红,李娜,刘玉清,李一石.口服美托洛尔引起血脂紊乱和β2肾上腺素受体基因多态性关系的研究[J].中国新药杂志,2010,19(18):1661-1665. 被引量:3

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部